Clinical trials data
Go/No-Go Task in depression and bipolar disorder trials: 79 registered studies
Every registered depression and bipolar disorder study on ClinicalTrials.gov that names the Go/No-Go Task in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered depression and bipolar disorder studies name it in an outcome measure
- 79
- Name it in a primary outcome, 42%
- 33 of 79
Tests named in the same studies
- 1
Affective Go/No-Go19 studies, 7 as a primary outcome
- 2
Stroop Color-Word Test14 studies, 4 as a primary outcome
- 3
Trail Making Test12 studies, 5 as a primary outcome
- 4
N-Back Task12 studies, 3 as a primary outcome
- 5
Digit Span Test10 studies, 3 as a primary outcome
- 6
Verbal Fluency9 studies, 2 as a primary outcome
- 7
Verbal Learning7 studies, 2 as a primary outcome
- 8
Card Sorting Test (Berg)7 studies, 1 as a primary outcome
- 9
Delay Discounting6 studies, 1 as a primary outcome
- 10
Task Switching Test5 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 7 | 0 |
| 2014 | 2 | 1 |
| 2015 | 1 | 1 |
| 2016 | 4 | 1 |
| 2017 | 3 | 0 |
| 2018 | 2 | 1 |
| 2019 | 9 | 5 |
| 2020 | 5 | 3 |
| 2021 | 6 | 3 |
| 2022 | 5 | 2 |
| 2023 | 10 | 7 |
| 2024 | 5 | 1 |
| 2025 | 5 | 1 |
| 2026 | 8 | 4 |
Phases and study sizes
By phase
- Phase 11 studies, 0 as a primary outcome
- Phase 1/21 studies, 0 as a primary outcome
- Phase 24 studies, 1 as a primary outcome
- Phase 34 studies, 0 as a primary outcome
- Phase 43 studies, 3 as a primary outcome
- Not applicable51 studies, 20 as a primary outcome
- Observational15 studies, 9 as a primary outcome
Participants per study
- Not applicable65 median, 45 to 114
- Observational150 median, 89 to 258
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 51 | 65 | 45 to 114 |
| Observational | 14 | 150 | 89 to 258 |
When depression and bipolar disorder trials measure it
Latest time point of each outcome
- Within a day17 outcomes, 7 as a primary outcome
- Up to 4 weeks15 outcomes, 5 as a primary outcome
- 1 to 3 months26 outcomes, 11 as a primary outcome
- 3 to 6 months9 outcomes, 4 as a primary outcome
- 6 to 12 months4 outcomes, 2 as a primary outcome
- Over 2 years4 outcomes, 2 as a primary outcome
- No duration given4 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
75 of the 79 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting20 studies, 7 as a primary outcome
- Not yet recruiting5 studies, 2 as a primary outcome
- Active, not recruiting4 studies, 4 as a primary outcome
- Completed38 studies, 15 as a primary outcome
- Stopped early6 studies, 3 as a primary outcome
- Status unknown6 studies, 2 as a primary outcome
What they test
- Behavioral30 studies, 14 as a primary outcome
- Drug18 studies, 7 as a primary outcome
- Device11 studies, 3 as a primary outcome
- Dietary supplement3 studies, 0 as a primary outcome
- Procedure1 studies, 0 as a primary outcome
- Diagnostic test2 studies, 1 as a primary outcome
- Radiation1 studies, 0 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Other14 studies, 8 as a primary outcome
- None given9 studies, 4 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States39 studies, 20 as a primary outcome
- United Kingdom9 studies, 1 as a primary outcome
- France8 studies, 2 as a primary outcome
- Canada5 studies, 2 as a primary outcome
- Germany3 studies, 2 as a primary outcome
- Israel2 studies, 1 as a primary outcome
- Belgium1 studies, 0 as a primary outcome
- Brazil1 studies, 0 as a primary outcome
- China1 studies, 1 as a primary outcome
- Hong Kong1 studies, 0 as a primary outcome
- Malaysia1 studies, 1 as a primary outcome
- Netherlands1 studies, 1 as a primary outcome
17 countries in all. A study with sites in several counts in each; 2 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed depression and bipolar disorder studies that name the Go/No-Go Task: 16 of 38, 42%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed depression and bipolar disorder studies that name the Go/No-Go Task | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 7, 18% | 776, 10% |
| Results on ClinicalTrials.gov only | 4, 11% | 1,139, 14% |
| A results paper only | 5, 13% | 1,711, 22% |
| Neither | 22, 58% | 4,327, 54% |
The 79 studies
79 studies match. 33 name the Go/No-Go Task in a primary outcome. Median size 75 participants. Median time to the primary outcome: 8 weeks.
Loading 79 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 7 | 0 |
| 2014 | 2 | 1 |
| 2015 | 1 | 1 |
| 2016 | 4 | 1 |
| 2017 | 3 | 0 |
| 2018 | 2 | 1 |
| 2019 | 9 | 5 |
| 2020 | 5 | 3 |
| 2021 | 6 | 3 |
| 2022 | 5 | 2 |
| 2023 | 10 | 7 |
| 2024 | 5 | 1 |
| 2025 | 5 | 1 |
| 2026 | 8 | 4 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 4, other 75. Interventional 64, observational 15.
As a primary outcomeSecondary or other outcomeThe Go/No-Go Task
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07848477 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07845409 | Start2027 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants138 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07651293 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants46 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07590999 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants106 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07533773 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07477470 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants120 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07427966 | Start2026 | PhaseObservational | ConditionsDepression and bipolar disorder | Participants600 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07258914 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Autism | Participants25 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07222306 | Start2026 | PhaseObservational | ConditionsDepression and bipolar disorder, Substance use and addiction, Anxiety, PTSD and OCD | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07201909 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants156 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07198100 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Obesity and diabetes | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07183748 | Start2025 | PhasePhase 2 | ConditionsDepression and bipolar disorder | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07091968 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Cancer | Participants60 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06972368 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06813313 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants108 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06809166 | Start2024 | PhasePhase 4 | ConditionsDepression and bipolar disorder, Obesity and diabetes | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06720571 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants24 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06557642 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants88 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06476626 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants200 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06376656 | Start2022 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Aging, frailty and exercise, Anxiety, PTSD and OCD | Participants400 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06145984 | Start2020 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06138691 | Start2023 | PhasePhase 1 | ConditionsDepression and bipolar disorder | Participants16 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06110559 | Start2021 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants124 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06049888 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05966532 | Start2023 | PhaseObservational | ConditionsDepression and bipolar disorder, Healthy volunteers | Participants276 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
Questions, answered from the data
How many depression and bipolar disorder trials use the Go/No-Go Task?
79 registered depression and bipolar disorder studies on ClinicalTrials.gov name it in an outcome measure, 33 of them in a primary outcome: 6% of the condition's 1,247 studies with a cognitive outcome, against 4% of all of them. It is the 7th most named test in depression and bipolar disorder trials.
Which tests do depression and bipolar disorder trials use with the Go/No-Go Task?
Affective Go/No-Go (19 studies), the Stroop Color-Word Test (14 studies) and the Trail Making Test (12 studies).
When do depression and bipolar disorder trials measure the Go/No-Go Task?
Half of the primary outcomes that name the Go/No-Go Task are measured within 8 weeks of the start, and the middle half from 1 week to 15 weeks. 31 primary outcomes give a duration.
How many completed depression and bipolar disorder trials that use the Go/No-Go Task have reported results?
16 of the 38 completed studies that name it, 42%, have reported results: 11 posted them on ClinicalTrials.gov, 12 have a results paper linked to the registry record, and 7 did both. The other 22 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Go/No-Go Task and Go/No-Go Game as one test family, so this page counts their studies together.
Run the Go/No-Go Task in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.